Fluorodeoxyglucose positron emission tomography of soft tissue tumours: Is a non-invasive determination of biological activity possible?

European Journal of Nuclear Medicine

Volumn 26, Issue 6, 1999, Pages 599-605

  Schulte, Michael ^a   Brecht Krauss, Doris ^b   Heymer, Berno ^b   Guhlmann, Albrecht ^b   Hartwig, Erich ^b   Sarkar, Michael R ^b   Diederichs, Christoph G ^b   Schultheiß, Markus ^b   Kotzerke, Jörg ^b   Reske, Sven N ^b  

^a UNIVERSITY HOSPITAL ULM   (Germany)

^b NONE

Author keywords

Fluorode oxyglucose; Sarcoma; Soft tissue neoplasms

Indexed keywords

FLUORODEOXYGLUCOSE F 18;

ADULT; AGED; ARTICLE; BENIGN TUMOR; BIOPSY; CANCER GRADING; CLINICAL TRIAL; DEVICE; DRUG UPTAKE; FEMALE; HUMAN; IONIZING RADIATION; LATENT PERIOD; MAJOR CLINICAL STUDY; MALE; MUSCULOSKELETAL SYSTEM; NONHODGKIN LYMPHOMA; OSSIFYING MYOSITIS; POSITRON EMISSION TOMOGRAPHY; PRESCHOOL CHILD; SARCOMA; SOFT TISSUE TUMOR; STATISTICAL ANALYSIS;

FEMALE; FLUORINE RADIOISOTOPES; FLUORODEOXYGLUCOSE F18; HUMANS; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; RADIOPHARMACEUTICALS; SOFT TISSUE NEOPLASMS; TOMOGRAPHY, EMISSION-COMPUTED;

EID: 0033056888     PISSN: 03406997     EISSN: None     Source Type: Journal    
DOI: 10.1007/s002590050427     Document Type: Article

References (26)

1. Enzinger FM, Weiss SW. Liposarcoma. In: Enzinger FM, Weiss SW eds. Soft tissue tumors. St. Louis Baltimore Berlin: Mosby; 1995: 431-466.
2. Enzinger FM, Weiss SW. Benign lipomatous tumors. In: Enzinger FM, Weiss SW eds. Soft tissue tumors. St. Louis Baltimore Berlin: Mosby; 1995: 381-430.
3. Enzinger FM, Weiss SW. General considerations. In: Enzinger FM, Weiss SW eds. Soft tissue tumors. St. Louis Baltimore Berlin: Mosby; 1995: 1-16.
4. Griffeth LK, Dehdashti F, McGuire AH, McGuire DJ, Perry DJ, Moerlein SM, Siegel BA. PET evaluation of soft-tissue masses with fluorine-18 fluoro-2-deoxy-D-glucose. Radiology 1992; 182: 185-194.
5. Nieweg OE, Pruim J, van Ginkel RJ, Hoekstra HJ, Paans AM, Molenaar WM, Koops HS, Vaalburg W. Fluorine-18-fluorodeoxyglucose PET imaging of soft-tissue sarcoma. J Nucl Med 1996; 37: 257-261.
6. 18F]FDG. J Comput Assist Tomogr 1990; 14: 960-962.
7. Adler LP, Blair HF, Makley JT, Williams RP, Joyce MJ, Leisure G, al Kaisi N, Miraldi F. Noninvasive grading of musculoskeletal tumors using PET. J Nucl Med 1991; 32: 1508-1512.
8. Eary JF, Conrad EU, Bruckner JD, Folpe A, Hunt KJ, Mankoff DA, Howlett AT. Quantitative [F-18]fluorodeoxyglucose positron emission tomography in pretreatment and grading of sarcoma. Clin Cancer Res 1998; 4: 1215-1220.
9. Kern KA, Brunetti A, Norton JA, Chang AE, Malawer M, Lack E, Finn RD, Rosenberg SA, Larson SM. Metabolic imaging of human extremity musculoskeletal tumors by PET. J Nucl Med 1988; 29: 181-186.
10. 18F]fluorodeoxyglucose. Ann Surg Oncol 1997; 4: 57-63.
11. Lucas JD, O'Doherty MJ, Wong JC, Bingham JB, McKee PH, Fletcher CD, Smith MA. Evaluation of fluorodeoxyglucose positron emission tomography in the management of soft-tissue sarcomas. J Bone Joint Surg Br 1998; 80: 441-447.
12. van Ginkel RJ, Hoekstra HJ, Pruim J, Nieweg OE, Molenaar WM, Paans AM, Willemsen AT, Vaalburg W, Koops HS. FDG-PET to evaluate response to hyperthermic isolated limb perfusion for locally advanced soft-tissue sarcoma. J Nucl Med 1996; 37: 984-990.
13. Broders AC, Hargrave R, Meyerding HW. Pathological features of soft tissue fibrosarcoma with special reference to the grading of its malignancy. Surg Gynecol Obstet 1939; 69: 267-275.
14. Coindre JM, Trojani M, Contesso G, David M, Rouesse J, Bui NB, Bodaert A, De Mascarel I, De Mascarel A, Goussot JF. Reproducibility of a histopathologic grading system for adult soft tissue sarcoma. Cancer 1986; 58: 306-309.
15. Enneking WF. A system of staging musculoskeletal neoplasms. Clin Orthop 1986; 204: 9-24.
16. Stollfuss JC, Glatting G, Friess H, Kocher F, Berger HG, Reske SN. 2-(fluorine-18)-fluoro-2-deoxy-D-glucose PET in detection of pancreatic cancer: value of quantitative image interpretation. Radiology 1995; 195: 339-344.
17. 18F]-fluoro-2-deoxy-D-glucose using aminopolyether supported nucleophilic substitution. J Nucl Med 1986; 27: 235-238.
18. Schmidlin P. Improved iterative image reconstruction using variable projection binning and abbreviated convolution. Eur J Nucl Med 1994; 21: 930-936.
19. Erlemann R, Reiser MF, Peters PE, Vasallo P, Nommensen B, Kusnierz-Glaz CR, Ritter J, Roessner A. Musculoskeletal neoplasms: static and dynamic Gd-DTPA-enhanced MR imaging. Radiology 1989; 171: 767-773.
20. Moulton JS, Blebea JS, Dunco DM, Braley SE, Bisset GS, Emery KH. MR imaging of soft-tissue masses: diagnostic efficacy and value of distinguishing between benign and malignant lesions. AJR Am J Roentgenol 1995; 164: 1191-1199.
21. Panicek DM, Gatsonis C, Rosenthal DI, Seeger LL, Huvos AG, Moore SG, Caudry DJ, Palmer WE, McNeil BJ. CT and MR imaging in the local staging of primary malignant musculoskeletal neoplasms: report of the Radiology Diagnostic Oncology Group. Radiology 1997; 202: 237-246.
22. Benedikt RA, Jelinek JS, Kransdorf MJ, Moser RP, Berrey BH. MR imaging of soft-tissue masses: role of gadopentetate dimeglumine. J Magn Reson Imaging 1994; 4: 485-490.
23. Crim JR, Seeger LL, Yao L, Chandnani V, Eckardt JJ. Diagnosis of soft-tissue masses with MR imaging: can benign masses be differentiated from malignant ones? Radiology 1992; 185: 581-586.
24. van der Woude H, Verstraete KL, Hogendoorn PC, Taminiau AH, Hermans J, Bloem JL. Musculoskeletal tumors: Does fast dynamic contrast-enhanced subtraction MR imaging contribute to the characterization? Radiology 1998; 208: 821-828.
25. Choi H, Varma DG, Fornage BD, Kim EE, Johnston DA. Soft-tissue sarcoma: MR imaging vs sonography for detection of local recurrence after surgery. AJR Am J Roentgenol 1991; 157: 353-358.
26. Pino G, Conzi GF, Murolo C, Schenone F, Magliani L, Imperiale A, Dato G, Panetta M, Toma S. Sonographic evaluation of local recurrences of soft tissue sarcomas. J Ultrasound Med 1993; 12: 23-26.